OLYMPUS CORP/S (OCPNY) – Analysts’ Weekly Ratings Updates

OLYMPUS CORP/S (OTCMKTS: OCPNY) recently received a number of ratings updates from brokerages and research firms:

  • 1/16/2020 – OLYMPUS CORP/S was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “
  • 1/8/2020 – OLYMPUS CORP/S was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $17.00 price target on the stock. According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “
  • 1/4/2020 – OLYMPUS CORP/S was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “
  • 1/2/2020 – OLYMPUS CORP/S was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $17.00 price target on the stock. According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “

OTCMKTS:OCPNY traded up $0.10 during mid-day trading on Monday, hitting $16.35. 3,830 shares of the stock traded hands, compared to its average volume of 15,611. The stock has a market capitalization of $22.33 billion, a price-to-earnings ratio of 327.00, a PEG ratio of 3.69 and a beta of 0.66. OLYMPUS CORP/S has a 52 week low of $6.26 and a 52 week high of $16.37. The firm’s 50 day moving average is $15.34 and its two-hundred day moving average is $13.44. The company has a quick ratio of 0.80, a current ratio of 1.23 and a debt-to-equity ratio of 0.33.

OLYMPUS CORP/S (OTCMKTS:OCPNY) last issued its earnings results on Wednesday, November 6th. The company reported $0.19 EPS for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.08. The company had revenue of $1.93 billion during the quarter, compared to the consensus estimate of $1.83 billion. As a group, research analysts predict that OLYMPUS CORP/S will post 0.44 EPS for the current year.

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices.

See Also: What is a Real Estate Investment Trust (REIT)?

Receive News & Ratings for OLYMPUS CORP/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OLYMPUS CORP/S and related companies with MarketBeat.com's FREE daily email newsletter.